Efficacy and safety of a sodium-glucose co-transporter-2 inhibitor versus placebo as an add-on therapy for people with type 2 diabetes inadequately treated with metformin and a dipeptidyl peptidase-4 inhibitor: a systematic review and meta-analysis of randomised controlled trials

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): DeBuitleir C, OConnor E, Satti MM, Shaw JAM, Liew A

Publication type: Article

Publication status: Published

Journal: Diabetic Medicine

Year: 2020

Volume: 38

Issue: 2

Print publication date: 01/02/2021

Online publication date: 26/09/2020

Acceptance date: 08/09/2020

ISSN (print): 0742-3071

ISSN (electronic): 1464-5491

Publisher: Wiley

URL: https://doi.org/10.1111/dme.14409

DOI: 10.1111/dme.14409

PubMed id: 32979231

Altmetrics provided by Altmetric

ePrints